INTRODUCTION
Congestive heart failure in the first days of life may be caused by multiple pathologic processes, including structural heart disease, severe anemia, arrhythmia, myocardiopathy, myocarditis, and others. Congenital arteriovenous malformation (AVM) is among the responsible entities that are often overlooked initially. These pathologic vascular structures in newborn infants are most commonly reported to occur in cranial, hepatic, or pulmonary locations and are typically accompanied by visible, palpable, or audible overlying external abnormalities. 1 -7 In addition to heart failure, such abnormal vascular structures have been associated with localized hemorrhage, consumption of hemostatic factors, and thromboembolic events. 3,8 -11 We present an infant with heart failure caused by an occult parascapular AVM and an associated intraparenchymal brain hemorrhage.
CASE REPORT
A 2720-g male infant was delivered to a 26-year-old multiparous woman from cephalic presentation by emergent cesarean delivery at term because of a non-reassuring fetal heart pattern. The pregnancy had been remarkable for suspected intrauterine growth retardation and oligohydramnios. No family history of thrombophilia or coagulopathy was found. Apgar scores were 5 and 8 at 1 and 5 minutes. Because of mild respiratory distress after initial resuscitation, he was placed on CPAP with good clinical response. Physical examination revealed no organomegaly or abnormal pulse pressure. Initial laboratory studies included hematocrit 58%, leukocyte count 16,000/mm 3 , and platelet count 89,000/mm 3 . A chest radiograph showed nonspecific changes with ''unremarkable heart and lungs.'' Later that evening, he was weaned to room air.
On day 1, he developed focal tonic-clonic jerking of the right arm. Intravenous phenobarbital was initiated, with later adjustments of anticonvulsant therapy as required for seizure control. Magnetic resonance imaging and computed cranial tomography without contrast revealed a large left posterior frontal intraparenchymal hemorrhage. No tumor, herniation, mass effect, hydrocephalus, or AVM was evident. The right anterior cerebral artery could not be definitely identified, although it was unclear whether this represented technical limitation or aberrant vascular development. All other intracranial vessels appeared normal. A left temporal seizure focus was noted on electroencephalogram. Laboratory studies showed the platelet count to be 68,000/mm 3 , prothrombin time (PT) 25 seconds (INR 2.5), partial thromboplastin time (PTT) 47 seconds, and fibrinogen 90 mg/dl. Fresh frozen plasma, platelets, and cryoprecipitate were administered.
At age 3 days, he developed increasing respiratory distress and oliguria. Chest radiography revealed cardiomegaly and increased pulmonary vascular markings. Physical examination at that time was notable only for generalized pitting edema and a liver edge 4 cm below the right costal margin. A two-dimensional echocardiogram revealed pulmonary hypertension and biventricular dysfunction, but no structural abnormality. The infant was intubated, given dobutamine, dopamine, albumin, and milrinone, and transferred to our intensive care nursery at 5 days of age.
Perinatal/Neonatal Case Presentation
Residual coagulation abnormalities prompted administration of additional fresh frozen plasma, cryoprecipitate, and platelets on admission to our nursery. Subsequently the PT, PTT, and fibrinogen remained within normal ranges. He received high-frequency oscillation for 2 days because of oxygenation difficulties. A repeat echocardiogram with examination of the great vessels on day 6 of life demonstrated a large vascular mass enveloping the left scapula. Differentiation between AVM, hemangioma, or other wellvascularized soft tissue tumor was difficult on Doppler interrogation and magnetic resonance angiography. The latter characterized the lesion as a 3Â3Â3-cm heterogeneous, well-vascularized mass with several arterial feeding vessels emerging from the left subclavian artery and a large superior vein draining into the left subclavian vein. No visible, palpable, or audible abnormality was evident externally over or near the vascular mass.
Prednisone was initiated to facilitate involution of the vascular mass. Although serial platelet counts had revealed a slow decrease from 109,000 to 82,000/mm 3 , the count rose to 196,000/mm 3 after prednisone administration and remained within normal limits. Inotropic infusions were gradually weaned and discontinued, while diuretics and digoxin were added to manage the associated heart failure. The infant was extubated, but remained tachypneic and required supplemental oxygen by nasal cannula.
Serial echocardiography found no improvement in cardiovascular function, whereas follow-up magnetic resonance angiography detected no regression of the vascular mass. The clinical course and increasing prominence of feeder vessels made the presence of an AVM most likely (Figure 1 ). The infant underwent two polyvinyl alcohol embolization procedures 2 weeks apart with significant involution of the vascular mass. Follow-up echocardiography revealed marked improvement in cardiac function and size. He was weaned subsequently from prednisone, nasal cannula, diuretics, and digoxin. Repeat brain imaging before hospital discharge revealed focal loss of brain substance corresponding to the previously observed hemorrhage with peripheral calcification, and no evidence for subsequent hemorrhage.
The infant was closely monitored after hospital discharge. He developed a cutaneous hemangioma on the left side of his neck at 3 months but had no apparent platelet trapping or hemodynamic compromise. The hemangioma was involuting by 6 months. Followup magnetic resonance angiography at age 5 months noted a slight increase in the size of the vascular mass (attributed to increased venous pooling), but blood flow to and from the AVM was markedly decreased. Cardiac failure did not recur. Review of growth curves at 6 months revealed height, weight, and head circumference to be tracking appropriately along the 5th, 10th, and 10th percentiles, respectively.
DISCUSSION
Clinical manifestations of a large AVM occur largely because of the large flow of arterial blood under high pressure throughout the cardiac cycle into the low-pressure venous bed. In addition to localized turbulence, vascular injury, stasis, and thrombosis, systemic consequences may include tachycardia, increased cardiac output, widened pulse pressure, ventricular dilatation, and heart failure. Although AVMs in older individuals are often acquired from trauma or other invasive insults, they are almost always congenital in newborn and young infants. The absence of cardiomegaly, organomegaly, and heart failure at birth is not uncommon, with gradual onset related to postnatal changes in pulmonary and systemic vascular resistance.
In a report of 156 infants with AVM of the central nervous system, liver, or lung, 57% developed heart failure and 59% died in infancy. 1 Although the most common locations of AVM in infants are intracranial, 2 pulmonary, 4 and hepatic, 5 occurrences in the trunk, neck, extremities, 2 spine, 12 alimentary tract, subclavian area, 13 -15 umbilicus, 16 and finger 17 have been reported. The AVM in the present case appears to be the first neonatal lesion reported in the parascapular region. Most AVMs severe enough to cause heart failure have physical clues to the location of the vascular mass, including overlying bruit, thrill, swelling, or cutaneous lesion. 1 -3,18,19 In the present case, no external clue to AVM was evident, even on careful reevaluation after the localizing results of the imaging studies were known.
The cerebral hemorrhage in this infant was not associated with prematurity, malpresentation, protracted labor, macrosomia, instrumental delivery, familial, or transplacental hemostatic abnormality. Possible mechanisms for intracranial hemorrhage in this term infant with a parascapular AVM include (1) a thromboembolic event originating from the AVM into a branch cortical vessel with disruption of cerebral hemodynamics, intravascular pressures, and endothelial integrity; (2) an occult intracranial aneurysm or other vascular anomaly in association with the remote AVM; or (3) coagulopathy caused by consumption of platelets and other hemostatic factors by the AVM. The last seems unlikely as a sufficient explanation because no bleeding was evident elsewhere and the coagulation profile became normal with the receipt of blood products and prednisone, long before resolution of the AVM. Although the infant had a possible anomaly of one anterior cerebral artery, that abnormality was in the opposite hemisphere from the hemorrhage. A small vascular anomaly below the detection limit of the imaging studies but at the site of the hemorrhage cannot be excluded. Most reports of hemorrhage with AVM have noted bleeding to occur at or very near the malformation, rather than a remote site. 20 Embolic events to the central nervous system from remote AVMs have been reported in older individuals. 3,19,21 -23 We speculate that the brain hemorrhage in this infant was caused by an12:5AVM-related thromboembolism that gained access to the arterial tree of the central nervous system by crossing the patent foramen ovale. It is possible that the cerebral hemorrhage in this infant was unrelated to the AVM, but the independent occurrence of two such rare events in the same term infant seems unlikely.
This case illustrates the importance of considering AVM in an atypical location in infants with congestive heart failure and no primary cardiac disease. The absence of external localizing signs on physical examination does not preclude an underlying AVM. In this case, the potential occurrence of remote complications from an AVM is suggested by the parenchymal brain hemorrhage. Such processes should be considered in infants with AVM and atypical associated clinical problems. Although sporadic embolic events from an AVM may be harmful, the successful hemodynamic outcome of this patient underscores the utility of carefully targeted interventional embolization. 5,12,19,21 -25 
